Nasment (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Nasment, is an imidazoline derivative presented as a nasal spray for nasal use. It relieves nasal congestion associated with the common cold, sinusitis, and allergic rhinitis in adults and children.

GNH USA supplies Nasment as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nasment, an imidazoline‑type nasal decongestant, is used to alleviate congestion in several upper‑respiratory conditions. - Common cold: reduces nasal blockage and improves airflow. - Sinusitis: decreases mucosal swelling to ease sinus drainage. - Allergic rhinitis: alleviates congestion caused by allergen‑induced inflammation.

Nasment may cause local or systemic reactions, most of which are mild and transient.

Common Side Effects: - Nasal burning or stinging sensation. - Mild headache. - Dryness of the nasal mucosa. - Sneezing. - Transient taste disturbance. - Mild epistaxis (nosebleed).

Serious or Rare Side Effects: - Persistent hypertension. - Severe nasal ulceration. - Allergic contact dermatitis. - Rebound congestion with prolonged use. - Cardiac arrhythmias in susceptible individuals. - Anaphylactic reaction (very rare).

Before using Nasment, consider the following safety points. - Prolonged use: limit to 3‑5 days to avoid rebound congestion. - Pre‑existing hypertension: use with caution and monitor blood pressure. - Cardiovascular disease: consult a healthcare professional before use. - Pregnancy and lactation: discuss risks with a physician as safety data are limited. - Children under 2 years: not recommended without medical advice. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nasment may interact with other medications that affect blood pressure or vascular tone.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may potentiate hypertensive effects. - Systemic decongestants (e.g., pseudoephedrine): increased risk of hypertension.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: possible reduction in efficacy. - Beta‑blockers: may blunt cardiovascular response. - Other nasal sprays (corticosteroids or antihistamines): monitor for additive irritation. - Herbal vasoconstrictors (e.g., yohimbine): observe for heightened blood pressure.